FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sanford Paul A
2. Date of Event Requiring Statement (MM/DD/YYYY)
9/27/2021 

3. Issuer Name and Ticker or Trading Symbol

Cigna Corp [CI]
(Last)        (First)        (Middle)

900 COTTAGE GROVE ROAD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
EVP Operations /
(Street)

BLOOMFIELD, CT 06002      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $.01 Par Value 8537.0000 D  
Common Stock, $.01 Par Value 253.9100 (1)I By 401(k) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) 2/28/2018 (2)2/28/2027 Common Stock, $.01 Par Value 95.0000 $149.1350 D  
Employee Stock Option (Right to Buy) 2/27/2020 (3)2/27/2029 Common Stock, $.01 Par Value 1826.0000 $183.4405 D  
Employee Stock Option (Right to Buy) 2/26/2021 (4)2/26/2030 Common Stock, $.01 Par Value 1847.0000 $192.0200 D  
Employee Stock Option (Right to Buy) 2/28/2019 (2)2/28/2028 Common Stock, $.01 Par Value 3092.0000 $197.3500 D  
Employee Stock Option (Right to Buy) 3/1/2022 (5)2/24/2031 Common Stock, $.01 Par Value 2677.0000 $213.8000 D  

Explanation of Responses:
(1) Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
(2) This option is fully vested.
(3) This option vests in three equal annual installments. The first installment became exercisable on February 27, 2020, the second installment became exercisable on February 27, 2021 and the third installment will become exercisable on February 27, 2022.
(4) This option vests in three equal annual installments. The first installment became exercisable on February 26, 2021, and the next two installments become exercisable on February 26, 2022 and February 26, 2023.
(5) This option vests in three equal annual installments beginning March 1, 2022.

Remarks:
Exhibit List: EX-24 Power of Attorney poasanford.txt

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Sanford Paul A
900 COTTAGE GROVE ROAD
BLOOMFIELD, CT 06002


EVP Operations

Signatures
By: Jill M. Stadelman, attorney-in-fact10/7/2021
**Signature of Reporting PersonDate

Cigna (NYSE:CI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cigna Charts.
Cigna (NYSE:CI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cigna Charts.